Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.98 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.98 |
| ▸ | USP2 | O75604 | 4/20 | 0.98 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.98 |
| ▸ | HAT1 | O14929 | 4/20 | 0.98 |
| ▸ | RBBP7 | Q16576 | 4/20 | 0.98 |
| ▸ | HTT | P42858 | 4/20 | 0.98 |
| ▸ | RECQL | P46063 | 3/20 | 0.98 |
| ▸ | CASP7 | P55210 | 3/20 | 0.98 |
| ▸ | MAPT | P10636 | 3/20 | 0.98 |
| ▸ | CASP1 | P29466 | 2/20 | 0.98 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.98 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.98 |
| ▸ | TST | Q16762 | 2/20 | 0.98 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.98 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.98 |
| ▸ | LMNA | P02545 | 1/20 | 0.98 |
| ▸ | HBB | P68871 | 1/20 | 0.98 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.98 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Riboflavin SCHEMBL1983532 | 1.00 | MEN1 (0.98) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL28003822 | 0.99 | MEN1 (0.96) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL246757 | 0.99 | MEN1 (0.96) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL1064647 | 0.99 | MEN1 (0.96) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL13373926 | 0.99 | MEN1 (1.00) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL7707 | 0.99 | MEN1 (1.00) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL5899262 | 0.99 | MEN1 (1.00) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL7706 | 0.99 | MEN1 (1.00) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL14146654 | 0.99 | MEN1 (1.00) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL12979917 | 0.99 | MEN1 (1.00) | MEN1KMT2AUSP2KDM4EHAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113795565-B | Tracer composition | 切尔西科技有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-119751771-A | Photopolymer holographic recording medium, grating, preparation method and equipment thereof | 珠海莫界科技有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-118576619-B | A composition containing vitamins and minerals | 深圳奥萨制药有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-118931526-A | CeO-based2Enhanced fluorescent probe and application thereof in detection of sulfide ions or sulfate reducing bacteria | 华中科技大学 | 2024-11-12 | — | — | CN | claimed |
| CN-118845988-A | Composite preparation for weight reduction after operation and preparation method thereof | 四川大学华西医院 | 2024-10-29 | — | — | CN | claimed |
| CN-118576619-A | A composition containing vitamins and minerals | 深圳奥萨制药有限公司 | 2024-09-03 | — | — | CN | claimed |
| CN-116685297-A | Tooth surface coloring composition | 爱欧白欧有限公司 | 2023-09-01 | — | — | CN | claimed |
| CN-114314574-A | Riboflavin sodium phosphate-assisted large-size graphene water-phase preparation method | 复旦大学 | 2022-04-12 | — | — | CN | claimed |
| CN-107286194-A | A kind of riboflavin phosphate process for producing sodium | 山西集翔生物工程有限公司 | 2017-10-24 | — | — | CN | claimed |
| CN-121628874-B | EC riboflavin kinase mutant and application thereof | 深圳希吉亚生物技术有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260076399-A1 | READY-TO-USE PARENTERAL NUTRITION FORMULATION | BAXTER INT (US) | 2026-03-19 | — | — | US | disclosed |
| WO-2026007754-A1 | CEO2-BASED ENHANCED FLUORESCENT PROBE AND USE THEREOF IN DETECTION OF SULFUR IONS OR SULFATE-REDUCING BACTERIA | 华中科技大学 | 2026-01-08 | — | — | WO | disclosed |
| US-12507721-B2 | Ready-to-use parenteral nutrition formulation | BAXTER INTERNATIONAL INC. (US) | 2025-12-30 | — | — | US | disclosed |
| CN-121108971-A | Preparation method of fluorescence reinforced anti-counterfeiting material and application of fluorescence reinforced anti-counterfeiting material in space-time information encryption | 华中科技大学 | 2025-12-12 | — | — | CN | disclosed |
| CN-101574521-A | Oral combination shielding indisposed taste | SS PHARMA CO LTD (JP) | 2009-11-11 | — | — | CN | disclosed |
| CN-101569610-A | Oral solid composition | SSP CO LTD (JP) | 2009-11-04 | — | — | CN | disclosed |
| CN-101410115-A | Compositions containing riboflavin and sesamin-class compounds | SUNTORY LTD (JP) | 2009-04-15 | — | — | CN | disclosed |
| CN-101282737-A | Herbal pharmaceutical composition for cartilage tissue regeneration and osteoarthritis treatment | KOREA MEDICAL SCIENCE INST (KR) | 2008-10-08 | — | — | CN | disclosed |
| EP-1941929-A1 | ELECTRODE STRUCTURE FOR IONTOPHORESIS COMPRISING SHAPE MEMORY SEPARATOR, AND IONTOPHORESIS APPARATUS COMPRISING THE SAME | TTI ELLEBEAU, INC. (JP) | 2008-07-09 | — | — | EP | disclosed |
| WO-2002049621-A1 | ENTERIC-COATED DRUG FORMULATIONS AND THEIR MANUFACTURE | LICENTIA OY (FI) | 2002-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076399-A1 | READY-TO-USE PARENTERAL NUTRITION FORMULATION | PROC, MMAB, SLC5A6 | MEN1 61/4885KMT2A 2892/4885USP2 1198/4885 |
| US-12507721-B2 | Ready-to-use parenteral nutrition formulation | PROC, SLC5A6, GC | MEN1 290/4885KMT2A 3369/4885USP2 1957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.